Related Experiment Video
Updated: Sep 26, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Impact of MMP-9 Genetic Polymorphism and Concentration on the Development of Coronary Artery Disease in Ukrainian
Oksana S Pogorielova1, Viktoriia V Korniienko2, Yaroslav D Chumachenko3
1Department of Internal Medicine with Center of Respiratory Medicine, Sumy State University, Sumy 40007, Ukraine.
Insights
Matrix metalloproteinase-9 (MMP-9) influences atherosclerosis, a key factor in coronary artery disease (CAD). AG-genotype carriers showed a reduced risk of myocardial infarction (MI) in the Ukrainian population.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Biochemistry
Background:
- Coronary artery disease (CAD) is a major cause of mortality in Europe, primarily driven by atherosclerosis.
- Matrix metalloproteinase-9 (MMP-9) plays a role in all phases of atherosclerosis, potentially contributing to CAD development.
Purpose of the Study:
- To investigate the association between MMP-9 and the development of CAD.
- To analyze the influence of MMP-9 genetic variations and plasma levels on CAD in a Ukrainian population.
Main Methods:
- Genotyping for the rs17567 polymorphic locus using real-time PCR.
- Measurement of MMP-9 plasma concentration via ELISA.
- Study included 25 patients with intact coronary arteries, 40 with acute coronary syndrome (ACS), and 63 with chronic coronary syndrome (CCS).
Main Results:
- AG-genotype carriers exhibited a significantly lower risk of myocardial infarction (MI) (P=0.023; OR=0.299).
- MMP-9 plasma concentration data was collected but not detailed in the abstract's main findings.
Conclusions:
- The rs17567 polymorphism in MMP-9 may be associated with a reduced risk of MI in the studied Ukrainian population.
- Further research is warranted to elucidate the precise role of MMP-9 in CAD pathogenesis and its clinical implications.
Abstract:
Coronary artery disease (CAD) is one of the leading causes of death in Europe. It is known that atherosclerosis is the primary risk factor of CAD development. MMP-9 is involved in all stages of atherosclerosis and thus may contribute to CAD emergence. To investigate the influence of MMP-9 on the (CAD) development 25 patients with intact coronary arteries (CA), 40 patients with acute coronary syndrome (ACS), and 63 patients with chronic coronary syndrome (CCS) were enrolled in the study. Real-time PCR was carried out for genotyping on the rs17567-polymorphic locus, and ELISA study was performed to measure the MMP-9 plasma concentration. It was found the lower risk of MI occurrence for AG-carriers (P =0.023; ORa = 0.299, 95% CI = 0.106-0.848) in Ukrainian population.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Single Nucleotide Polymorphisms-SNPs
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Role of Matrix Metalloproteases in Degradation of ECM